Skip to main content
Clinical Trials/NCT00244790
NCT00244790
Completed
Not Applicable

The Effects of Obesity and Protein Intake on the Kidney

Indiana University School of Medicine1 site in 1 country50 target enrollmentApril 2004
ConditionsKidney Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Diseases
Sponsor
Indiana University School of Medicine
Enrollment
50
Locations
1
Primary Endpoint
glomerular filtration rate
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to determine if being overweight and eating lots of protein causes separate changes in the kidney that lead to kidney disease over time. These questions are important because the number of people who have kidney disease is quickly growing. If being overweight and eating lots of protein is found to cause kidney disease, then doctors may be able to limit the number of people with kidney disease by recommending weight loss and eating less protein

Detailed Description

The purpose of this study is to test the hypothesis that being obese leads to changes in kidney function that are independent of, and enhanced by, high dietary protein intake. Kidney function will be measured by the kidney's ability to filter blood and by the amount of protein in the urine. The hypothesis will be tested in the following manner: The first part of the study will involve a crossover design comparing kidney function in obese people with stable weights on a low and high protein diet ("Low/High Protein Study"). The second part of the study will compare kidney function in obese people before and after weight reduction surgery ("Before/After Surgery Study"). Since certain changes in kidney function may lead to kidney disease over time, it is important to confirm the effects of obesity and dietary protein intake on the kidney, especially with the current rise in obese people and the popularity of high protein diets.

Registry
clinicaltrials.gov
Start Date
April 2004
End Date
April 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Allon Friedman, MD

MD

Indiana University

Eligibility Criteria

Inclusion Criteria

  • Greater than 18 years of age
  • Ability to give informed consent
  • Not pregnant and using appropriate contraceptive methods, or not of childbearing potential
  • BMI of 30 or higher

Exclusion Criteria

  • Iodine or shellfish allergy
  • History of adverse reaction to intravenous contrast
  • Dialysis dependence
  • Diagnosis of diabetes mellitus or taking medicine for diabetes mellitus

Outcomes

Primary Outcomes

glomerular filtration rate

Time Frame: days

Study Sites (1)

Loading locations...

Similar Trials